SINGAPORE — At five years old, Oscar Saxelby-Lee has already gone through more than what most people will do in a lifetime.
Oscar is battling acute lymphoblastic leukaemia – a rare form of aggressive cancer that has so far rejected all forms of treatment.
The small boy spent most of 2019 – 10 months in total – in isolation wards as doctors fought to find a way to save his life.
Most children his age would be starting school about now after enjoying life, playing and learning.
Oscar has had a very different time, undergoing four regimes of chemotherapy, a stem cell transplant, and treatment where healthy cells are injected into him.
They have all failed – the cancer remains in Oscar’s blood and will kill him in months if left to itself.
Still, there is hope.
The latest experimental treatment, developed in Singapore, might save his life.
The boy from Worcester, England has flown here for a new form of treatment, in which immune cells from a patient’s blood is drawn and equipped with a Chimeric Antigen Receptor (CAR-T).